Korean J Gastroenterol.  2009 Oct;54(4):261-263. 10.4166/kjg.2009.54.4.261.

Increased Short- and Long-term Risk of Inflammatory Bowel Disease after Salmonella or Campylobacter Gastroenteritis. Gastroenterology 2009;137:495-501

• Lee J

• KMID: 783234
• DOI: http://doi.org/10.4166/kjg.2009.54.4.261

Abstract

No abstract available.

Reference

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126:1504–1517.

2. Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis. 2006; 19:475–484.

3. Barnich N, Darfeuille-Michaud A. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2007; 13:5571–5576.

4. Stallmach A, Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. In-flamm Bowel Dis. 2002; 8:213–218.

5. Barnich N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli and Crohn’ disease. Curr Opin Gastroenterol. 2007; 23:16–20.

6. Blaser MJ, Hoverson D, Ely IG, et al. Studies of Campylobacter jejuni in patients with inflammatory bowel disease. Gastroenterology. 1984; 86:33–38.

7. Taylor-Robinson S, Miles R, Whitehead A, et al. Salmonella infection and ulcerative colitis. Lancet. 1989; 1:1145.

8. Mylonaki M, Langmead L, Pantes A, et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol. 2004; 16:775–778.

9. Boyanova L, Gergova G, Spassova Z, et al. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn Microbiol Infect Dis. 2004; 49:71–74.

10. Bayerdorffer E, Hochter W, Schwarzkopf-Steinhauser G, et al. Bioptic microbiology in the differential diagnosis of enterocolitis. Endoscopy. 1986; 18:177–181.

11. De Hertogh G, Aerssens J, Geboes KP, et al. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J Gastroenterol. 2008; 14:845–852.

12. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134:577–594.

13. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’ disease. Gastroenterology. 2004; 127:412–421.

14. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2D phylogenetic group in inflammatory bowel disease. Gut. 2007; 56:669–675.

15. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104:13780–13785.

16. Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis. 2006; 42:498–506.

17. Ternhag A, Torner A, Svensson A, et al. Short- and longterm effects of bacterial gastrointestinal infections. Emerg Infect Dis. 2008; 14:143–148.

18. Banks BM, Korelitz BI, Zetzel L. The course of nonspecific ulcerative colitis: review of twenty years experience and late results. Gastroenterology. 1957; 32:983–1012.

19. Simonsen J, Strid MA, M⊘lbak K, et al. Sero-epidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect. 2008; 136:895–902.